Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
QuadGT Resource Report Resource Website 1+ mentions |
QuadGT (RRID:SCR_000073) | QuadGT | software resource | Software package for calling single-nucleotide variants in four sequenced genomes comprising a normal-tumor pair and the two parents. Genotypes are inferred using a joint model of parental variant frequencies, de novo germline mutations, and somatic mutations. The model quantifies the descent-by-modification relationships between the unknown genotypes by using a set of parameters in a Bayesian inference setting. Note that you can use it on any subset of the four related genomes, including parent-offspring trios, and normal-tumor pairs without parental samples. | single-nucleotide variant, sequenced genome, genotype, genome |
is listed by: OMICtools has parent organization: University of Montreal; Quebec; Canada |
Normal, Tumor, Cancer | Terry Fox Research Institute ; Canadian Institutes for Health Research ; Canada National Sciences and Engineering Research Council |
PMID:23734724 | Free, Available for download, Freely available | OMICS_02108 | SCR_000073 | 2026-02-07 02:05:16 | 1 | |||||
|
Experimental Pharmacology and Oncology Berlin-Buch Resource Report Resource Website 1+ mentions |
Experimental Pharmacology and Oncology Berlin-Buch (RRID:SCR_003954) | EPO | commercial organization | A small and medium-sized enterprise (SME) that has expertise in preclinical pharmacology, pharmacokinetics, and toxicology for the characterization of novel anticancer therapeutics and predictive biomarkers like: cytostatics, biologicals (peptides, antibodies), (anti)-hormones, immunomodulators (cytokines), and gene therapeutics. EPO has modern laboratories licensed for animal experiments and gene technology (S2) and a broad panel of murine and human tumor models growing in immunocompetent (SPF-quality, syngeneic strains) or immunodeficient mice (nude, SCID, NOD/SCID). EPO has established imaging technologies to monitor in vivo tumor growth. | tumor model, pharmaceutical, oncology, in vitro, in vivo, antitumor, preclinical, pharmacology, pharmacokinetics, toxicology, anticancer, therapeutic, biomarker, imaging, testing, validation, target | is related to: OncoTrack | Tumor, Cancer | nlx_158355 | SCR_003954 | EPO - Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology GmbH, Experimental Pharmacology & Oncology Berlin-Buch, Experimental Pharmacology & Oncology Berlin-Buch GmbH, EPO Berlin-Buch GmbH, EPO-GmbH | 2026-02-07 02:06:11 | 2 | |||||||
|
Alacris Theranostics Resource Report Resource Website |
Alacris Theranostics (RRID:SCR_003953) | Alacris | commercial organization | Commercial organization that uses next generation sequencing technologies coupled with computational modeling of tumor and somatic tissues in order to identify individualized therapies for cancer patients. The company also uses these technologies to help pharmaceutical partners stratify patients for their clinical trials. Alacris has an exclusive worldwide commercial license for the computational modeling of tumors and somatic tissues using proprietary computational systems modeling technologies ModCell developed at the Max Planck Institute for Molecular Genetics (MPI-MG) in Berlin coupled with next generation sequencing and genotyping technology developed at Harvard Medical School in Boston. The company also is building up the first next generation sequencing center in Europe for clinical operations. | next generation sequencing, computational modeling, clinical trial, somatic tissue, genotyping, genomics, oncogenomics, diagnostics, therapy, disease model, drug, personalized medicine, biomarker, drug development, tumor model, analysis, oncology | is related to: OncoTrack | Tumor, Cancer | nlx_158354, grid.473915.d | https://ror.org/04a0gnr15 | SCR_003953 | Alacris Theranostics GmbH | 2026-02-07 02:06:13 | 0 | ||||||
|
deStruct Resource Report Resource Website 1+ mentions |
deStruct (RRID:SCR_004747) | deStruct | software resource | A software tool for identifying structural variation in tumour genomes from whole genome illumina sequencing. | structural variation, genome, genomics |
is listed by: OMICtools has parent organization: Google Code |
Tumor, Cancer | Open unspecified license | OMICS_00314 | SCR_004747 | deStruct - Bioinformatics tool for identifying structural variation in tumour genomes | 2026-02-07 02:06:53 | 7 | ||||||
|
Althia Resource Report Resource Website |
Althia (RRID:SCR_003918) | Althia | commercial organization | A biomedical company in Spain focused on the development of new tools for diagnosis and personalized treatment of oncological diseases and precancerous. It has three areas of activity in permanent innovation: Assistance in Diagnosis / Prognosis in solid and hematological tumors, Translational Research covering the gap between basic and clinical research and advanced radiotherapy treatments based image-guided single dose (SD-IGRT). Their objectives are: * Provide an integrated tissue and tumor molecular phenotype analysis using the most advanced technologies in diagnosis, to guide the most appropriate treatment for each patient. * Discover and validate molecular patterns by molecular systems and platforms including pathology, to generate predictive algorithms through computational biology, evolution and determining the response of patients with a particular tumor profile. Althia has laboratories equipped with the most advanced equipment and technologies in Barcelona and Granada Genyo Center, with offices in Madrid. | oncology, diagnosis, prognosis, solid tumor, hematological tumor, translational, radiation, phenotype, analysis, pathology, hematology, hereditary | is related to: PRECISESADS | Cancer, Tumor, Solid tumor, Hematological tumor, Precancer | nlx_158279 | SCR_003918 | Althia Health Ltd., Althia Health, Advanced Laboratories of Translational Health, SL, S.L. | 2026-02-07 02:06:10 | 0 | |||||||
|
mutationSeq Resource Report Resource Website 10+ mentions |
mutationSeq (RRID:SCR_006815) | mutationSeq | software resource | A software suite using feature-based classifiers for somatic mutation prediction from paired tumour/normal next-generation sequencing data. mutationSeq has the advantages of integrating different features (e.g., base qualities, mapping qualities, strand bias, and tailed distance features), and validated somatic mutations to make predictions. Given paired normal/tumour bam files, mutationSeq will output the probability of each candidate site being somatic. | next-generation sequencing, somatic mutation, tumor, normal |
is listed by: OMICtools is related to: JointSNVMix has parent organization: BC Cancer Agency |
Tumor, Normal | PMID:22084253 | OMICS_00086 | SCR_006815 | 2026-02-07 02:07:34 | 24 | |||||||
|
Saint-Luc Tumour Bank Resource Report Resource Website 1+ mentions |
Saint-Luc Tumour Bank (RRID:SCR_008714) | Saint-Luc Tumor Bank | biomaterial supply resource, material resource | When a patient suffering or thought to be suffering from cancer is cared for, samples are often taken to determine the precise diagnosis and to determine any treatment necessary. After this essential stage of the patient''s care, unused biological material is sometimes left over. This material is an essential and precious tool for research into cancer. For this reason, patients can decide to make the material available to researchers the world over who study either the development mechanism of cancer or the new treatments available. Residual samples are centralized and stored in the Tumor Bank at the Cliniques Universitaires Saint-Luc Cancer Centre. The research carried out on this material primarily benefits cancer patients. It can help improve existing treatments or discover new drugs, and also allows new diagnostic tools to be tested. Any financial profits obtained from assessing the results obtained are entirely reinvested in the work of the Cancer Centre''s Tumour Bank and in new research projects at the Catholic University of Louvain. Using and sharing material, and verification and retrospective analysis of clinical data, all comply with strict rules. As with donations of blood, marrow or organs, an Ethics Committee oversees the operations of the Tumour Bank and research projects. This committee is responsible for ensuring compliance with current Belgian and legal texts, especially those concerning the protection of patient privacy and rights. | clinical data, tumor, cancer |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Cliniques Universitaires Saint-Luc Cancer Centre |
Tumor, Cancer | Public?: This material can be made available to researchers the world over who study either the development mechanism of cancer or the new treatments available. Any financial profits obtained from assessing the results obtained are entirely reinvested in the work of the Cancer Centre''s Tumour Bank and in new research projects at the Catholic University of Louvain. | nlx_12735 | SCR_008714 | Cliniques Universitaires Saint-Luc Cancer Center Tumor Bank, Saint-Luc Cancer Centre Tumour Bank, Saint-Luc Biobank or Tumour Bank, Cliniques Universitaires Saint-Luc Cancer Centre Tumour Bank | 2026-02-07 02:14:21 | 1 | ||||||
|
Developmental Therapeutics Program Resource Report Resource Website 500+ mentions |
Developmental Therapeutics Program (RRID:SCR_003057) | DTP | funding resource, portal, data or information resource, topical portal, service resource | Portal for preclinical information and research materials, including web-accessible data and tools, NCI-60 Tumor Cell Line Screen, compounds in vials and plates, tumor cells, animals, and bulk drugs for investigational new drug (IND)-directed studies. DTP has been involved in the discovery or development of more than 70 percent of the anticancer therapeutics on the market today, and will continue helping the academic and private sectors to overcome various therapeutic development barriers, particularly through supporting high-risk projects and therapeutic development for rare cancers. Initially DTP made its drug discovery and development services and the results from the human tumor cell line assay publicly accessible to researchers worldwide. At first, the site offered in vitro human cell line data for a few thousand compounds and in vitro anti-HIV screening data for roughly 42,000 compounds. Today, visitors can find: * Downloadable in vitro human tumor cell line data for some 43,500 compounds and 15,000 natural product extracts * Results for 60,000 compounds evaluated in the yeast assay * In vivo animal model results for 30,000 compounds * 2-D and 3-D chemical structures for more than 200,000 compounds * Molecular target data, including characterizations for at least 1,200 targets, plus data from multiple cDNA microarray projects In addition to browsing DTP's databases and downloading data, researchers can request individual samples or sets of compounds on 96-well plates for research, or they can submit their own compounds for consideration for screening via DTP's online submission form. Once a compound is submitted for screening, researchers can follow its progress and retrieve data using a secure web interface. The NCI has collected information on almost half a million chemical structures in the past 50 years. DTP has made this information accessible and useful for investigators through its 3-D database, a collection of three-dimensional structures for more than 200,000 drugs. Investigators use the 3-D database to screen compounds for anticancer therapeutic activity. Also available on DTP's website are 127,000 connection tables for anticancer agents. A connection table is a convenient way of depicting molecular structures without relying on drawn chemical structures. As unique lists of atoms and their connections, the connection tables can be indexed and stored in computer databases where they can be used for patent searches, toxicology studies, and precursor searching, for example., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | cell line, drug discovery, drug development, drug, treatment, therapy, biopharmaceutical, bortezomib, paclitaxel, romidepsin, eribulin, sipuleucel-t, anticancer therapeutic, compound, natural product extract, animal model, in vivo, in vitro, chemical structure, chemical, structure, anti-hiv, anticancer, molecular structure, database, chemotherapeutic agent, testing, drug synthesis, chemistry, grant, contract, information technology, molecular pharmacology, natural product, pharmaceutical, screening technology, toxicology, pharmacology, screening, FASEB list |
is used by: NIF Data Federation is related to: Integrated Cell Lines has parent organization: National Cancer Institute |
Cancer, Tumor | NCI | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-30447 | https://medschool.cuanschutz.edu/colorado-cancer-center/research/research-programs/developmental-therapeutics | SCR_003057 | Developmental Therapeutics Program NCI/NIH | 2026-02-11 10:56:41 | 562 | ||||
|
Arizona Cancer Center Tumor Bank Resource Report Resource Website |
Arizona Cancer Center Tumor Bank (RRID:SCR_003544) | AZCC Tumor Bank | biomaterial supply resource, tissue bank, material resource | TACMASS collects, preserves, and banks biospecimens obtained from Arizona Cancer Center surgical patients who are seen by University Medical Center surgeons and oncologists. Biospecimens collected at the time of surgery include fresh surgical tissue, blood and urine. Serum, plasma and genomic DNA are harvested from the whole blood. AZCC Members and collaborators may request the use of banked biospecimens through TACMASS. The patient's surgeon or oncologist is responsible for consenting the patient for submission of surgical specimens to the AZCC BioRepository (IRB #06-0609-04, Setsuko Chambers, PI). The surgeon and the Department of Pathology attending physicians and residents are responsible for identifying appropriate tissue for banking that will not compromise pathological diagnosis. Tumor and/or normal adjacent tissue, identified by gross examination, that will not be needed for pathological diagnosis are preserved by fixing in formalin, snap freezing, and/or fixing in RNALater. Histological diagnosis is rendered on each piece of formalin-fixed and snap frozen tissue by Hematoxylin and Eosin staining (H&E). Everyone involved in submitting specimens to the Tumor Bank must maintain a current CITI Certification. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Arizona; Arizona; USA |
Cancer, Tumor | nlx_10808 | SCR_003544 | 2026-02-11 10:56:45 | 0 | |||||||||
|
Sunnybrook Tumour Bank Resource Report Resource Website |
Sunnybrook Tumour Bank (RRID:SCR_004138) | Sunnybrook Tumour Bank | biomaterial supply resource, tissue bank, material resource | Sunnybrook Research Institute''s tumour bank provides a mechanism for the optimal collection, storage and distribution of human tissue for investigative purposes. We collect both freshly frozen and formalin-fixed paraffin-embedded tumour and normal samples, retrospectively and prospectively (informed consent and confidential consent is obtained from patients before sample collection). We offer the 1. Distribution of tissue and data to interested investigators after approval from the institutional research ethics board and 2. Collaboration with various research investigators. Our mandate is to design, implement and manage the structures and processes to ensure the timely provision of tissue samples and associated data. We are currently building bank on four disease sites: breast, prostate, colorectal, gynecological. We are also creating and maintaining a database with a tissue tracking and inventory system, using TissueMetrix software. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Toronto; Ontario; Canada |
Tumor | nlx_16022 | SCR_004138 | Sunnybrook Research Institute Tumor bank, Sunnybrook Research Institute Tumour bank | 2026-02-11 10:56:49 | 0 | ||||||||
|
Ludwig Boltzman Tumour Bank Resource Report Resource Website |
Ludwig Boltzman Tumour Bank (RRID:SCR_004322) | Ludwig Boltzmann Tumor Bank | biomaterial supply resource, tissue bank, material resource | As a basis for the experimental cluster projects, and for further future projects a collection of various biological specimens of cancer patients shall be established. All participating Ludwig Boltzmann Institutes (LBIs) are supplying biological specimens from tumor patients and clinical documentation. At the LBI for Gynecology and Gynecologic Oncology a tumor bank for biological specimens from gynecologic cancer patients already exists. All the procedures for sample processing and storage are well established. Existing equipment for storing tissue specimens at -196 degrees C can be used. Materials from the following malignant diseases are collected: Breast cancer Colorectal cancer Neuroendocrine tumors (NET) (Small cell lung cancer (SCLC) and Carcinoid tumors) Types of biological materials: Tissue (fresh frozen) Bone marrow Blood (serum/plasma/cell fractions) Pleural effusions Ascitic fluids Sputum Bronchial lavage Stool The biological specimens are initially processed at the respective LBIs or at their connected lab facilities. Enrichment of blood samples for disseminated tumor cells is done at the LBI for Gynecology and Gynecologic oncology. Long time storage of all materials is done at appropriate temperatures at the same institution. This LBI also coordinates the logistics. All relevant sample-specific and clinical data are surveyed at the respective LBIs and stored centralized in an on-line data bank in anonymized form, respecting all relevant regulations on data protection and security. | tissue, bone marrow, blood, serum, plasma, cell fraction, pleural effusion, ascitic fluid, sputum, bronchial lavage, stool, tumor cell, fresh frozen, frozen, tumor, cancer, breast cancer, colorectal cancer, neuroendocrine tumor, small cell lung cancer, carcinoid tumor, gynecologic cancer, clinical data, bodily fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Ludwig Boltzmann Cluster Translationale Onkologie |
Tumor, Cancer, Breast cancer, Colorectal cancer, Neuroendocrine tumor, Small cell lung cancer, Carcinoid tumor, Gynecologic cancer | nlx_33431 | SCR_004322 | Ludwig Boltzmann Gesellschaft Tumor Bank | 2026-02-11 10:56:52 | 0 | |||||||
|
Biorepository Alliance of Georgia for Oncology Resource Report Resource Website |
Biorepository Alliance of Georgia for Oncology (RRID:SCR_004184) | BRAG-Onc | biomaterial supply resource, tissue bank, material resource |
THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 17, 2013. The Georgia Cancer Specimen and Tissue Bank is committed to a safe and reliable supply of tissue and cell products for research purposes. Work has begun already to build the state tumor bank initiative with operating sites in several locations through the state. We are confident that our results will yield a strong program that will benefit all Georgians and contribute to significant advances in cancer research and knowledge. |
is listed by: One Mind Biospecimen Bank Listing | Cancer, Tumor | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_20991 | SCR_004184 | Bio-Repository Alliance of Georgia for Oncology, Georgia Cancer Specimen and Tissue Bank, Bio-Repository Alliance of Georgia for Oncology Tissue and Tumor Bank | 2026-02-11 10:56:52 | 0 | |||||||
|
Medical College of Georgia Tumor Bank Resource Report Resource Website |
Medical College of Georgia Tumor Bank (RRID:SCR_004336) | MCG Tumor Bank | biomaterial supply resource, tissue bank, material resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented August 31, 2016. The MCG Tumor Tissue and Serum Repository or tumor bank, located in the Department of Pathology, Murphey Pathology Building, was established with support from the Georgia Cancer Coalition (GCC). Its mission is to provide researchers access to high quality annotated specimens, an essential requirement for cancer research. The repository collection includes a variety of specimen types, such as tumor tissue and cells, blood and other biofluids as well as normal specimens used as controls. The quality of all specimens is reviewed by a pathologist, and the information is captured in the tumor bank''s database. An imaging system will be used in the future to capture this information. Human-derived specimens are a very precious resource, and therefore the operations of the tumor bank are overseen by an advisory board, representing GHSU and other stakeholders, to ensure that the specimens are properly utilized and the privacy of specimen donors is protected. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Medical College of Georgia; Georgia; USA |
Tumor | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_35211 | http://www.mcg.edu/CANCER/shared/tumor/ | SCR_004336 | GHSU Cancer Center Tumor Bank, MCG Tumor Tissue and Serum Repository | 2026-02-11 10:56:52 | 0 | ||||||
|
Canadian Breast Cancer Foundation Tumor Bank Resource Report Resource Website 1+ mentions |
Canadian Breast Cancer Foundation Tumor Bank (RRID:SCR_004214) | CBCF TB | biomaterial supply resource, tissue bank, material resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented May 18, 2022. A tumor bank that provides a large collection of cancer specimens, from breast and other cancers, annotated with clinical information. The CBCF TB enables researchers to address unanswered questions concerning the prognosis and treatment of breast cancer and other cancers. The CBCF TB website is also directed to participants interested in donating tumor tissue or blood. Biological specimens such as blood, urine, bone marrow, and ascites (fluid that sometimes collects in the abdomen) contain genetic information, just as tumor tissue does. These samples can be used in studies that may help researchers see how people with certain genetic make-ups respond to certain treatments. It can also explain why different people have different health problems. CBCF TB, formerly ARTB, was created by a merger of components of two existing Tumor-banking initiatives, the CLS Repository in Calgary and the Tumor bank of the PolyomX Program in Edmonton. | clinical information, clinical |
is listed by: One Mind Biospecimen Bank Listing is related to: Canadian Tumour Repository Network has parent organization: Canadian Breast Cancer Foundation |
Breast cancer, Tumor, Cancer | Canadian Breast Cancer Foundation ; Alberta Cancer Foundation |
THIS RESOURCE IS NO LONGER IN SERVICE | nlx_143637 | http://www.abtumorbank.com/ | SCR_004214 | Canadian Breast Cancer Foundation Alberta Research Tumor Bank, ARTB, CBCF Tumor Bank, Alberta Research Tumor Bank | 2026-02-11 10:56:50 | 3 | ||||
|
Southwest France Tumour Bank Resource Report Resource Website |
Southwest France Tumour Bank (RRID:SCR_004574) | SW France Tumor Bank | biomaterial supply resource, tissue bank, material resource | The Virtual Tumour Bank of the Canceropole Grand Sud-Ouest''s mission is to federate the cancer research of four French regions: Aquitaine, Languedoc-Roussillon, Limousin and Midi-Pyrenees. This site allows access to an inventory of the specimens stored in the tumor banks of the Greater South-West region, within the laboratories of Pathology of the University Hospital Centers and Cancer Centers of Bordeaux, Limoges, Montpellier, Nimes and Toulouse. You may search by disease or multiple criteria. These specimens are removed from patients primarily to confirm and accurately characterize their cancer diagnosis, and are therefore stored by the tumor bank for diagnostic and/or therapeutic purposes. These samples can be re-qualified for scientific research pending that a number of conditions are met, including the absence of refusal from the person (in compliance with French regulations). So far, the tumor bank is a major tool for cancer treatment and research. This inventory is a further evidence of the coordination effort between the eight concerned tumor banks that have been mobilized at the service of patients and research within the framework of the Canceropole Grand Sud-Ouest programs. These biological resources are made available to research groups that conduct basic or translational programs in the field of oncology. They will not be made available for projects in fields other than oncology. | tumor, tissue, tumor tissue, serum, plasma, bodily fluid, frozen, liquid nitrogen, paraffin, dmso, dry, cancer, neoplasm, malignant, benign, oncology | is listed by: One Mind Biospecimen Bank Listing | Tumor, Cancer, Neoplasm, Malignant, Benign | French National Cancer Institute | Public / Varying: These biological resources are made available to research groups that conduct basic or translational programs in the field of oncology. They will not be made available for projects in fields other than oncology. The access to clinical, Anatomo-pathological and biological data is strictly under the responsibility of each Tumour Bank. | nlx_56834 | SCR_004574 | SW France Virtual Tumor Bank, Southwest France Tumor Bank, Canc��rop��le Grand Sud-Ouest Virtual Tumour Bank, GSO virtual biobank, Southwest France Virtual Tumor Bank, SW France Tumour Bank, Canceropole Grand Sud-Ouest Virtual Tumour Bank, Tumorotheque Virtuelle du Canceropole GSO | 2026-02-11 10:56:55 | 0 | |||||
|
Canadian Tumour Repository Network Resource Report Resource Website 1+ mentions |
Canadian Tumour Repository Network (RRID:SCR_004192) | CTRNet | biomaterial supply resource, tissue bank, material resource | The Canadian Tumour Repository Network (CTRNet) is a not-for-profit consortium of leading provincial tumor banks and programs that furthers Canadian health research. CTRNet provides interested researchers with a streamlined process to obtain quality human tissue and human tissue products from member tumor banks. The benefits of working with CTRNet.ca include: * The ability for researchers to search for quality controlled tissue samples from Canada''''s leading tumor banks in one central location and for biobanks to display and make their biospecimens available for research users. * Learning opportunities in tissue handling, research design and relevant technology training and innovations. * Invitation to CTRNet workshops and conferences. * A resource for current news links and discussion forums about cancer research and tumor banking. The vision of CTRNet is to create new opportunities for translational cancer research that will improve cancer outcomes in Canada and beyond. Through the creation and maintenance of an online pan-Canadian network, researchers will gain unprecedented access to a new and comprehensive source of tissue and clinical data. The network is a sustainable resource and operates according to the highest scientific and ethical standards for research to benefit all Canadians. Currently CTRNet has the following member banks: * CBCF Tumor Bank Alberta * Manitoba Tumour Bank * Ontario Tumour Bank * British Columbia Cancer Agency Tumour Tissue Repository (BCCA-TTR) * Le r��seau de recherche en cancer du FRSQ * NCIC Clinical Trials Group |
is listed by: One Mind Biospecimen Bank Listing is related to: British Columbia Tumour Tissue Repository is related to: Ontario Tumour Bank is related to: Cancer Research Network of the FRSQ is related to: Manitoba Breast Tumor Bank is related to: Canadian Breast Cancer Foundation Tumor Bank |
Tumor | Canadian Institutes of Health Research | nlx_21725 | SCR_004192 | CTRNet.ca, Canadian Tumor Repository Network | 2026-02-11 10:56:50 | 3 | |||||||
|
Moffitt Cancer Center Tissue Core Resource Report Resource Website |
Moffitt Cancer Center Tissue Core (RRID:SCR_004406) | MCC TC | biomaterial supply resource, tissue bank, material resource | A central tissue repository at Moffitt specializing in protocol-driven human tissue collection, storage, processing and dissemination. Tissue Core provides investigators with access to high quality, well-annotated human specimens obtained from representative of the patient populations. The advent of powerful molecular technologies has opened the door to developing more effective treatments of patients with cancer. Access to high quality specimens with associated clinical, treatment, recurrence outcome data will be critical to developing and validating the tests needed for diagnosis and prediction of response to therapy. Since its commencement in 1993, the Tissue Core has collected more than 8,000 cases of human liquid cancers and solid primary and metastatic tumors both malignant and benign with adjacent normal, from variety of sites and diagnoses. Collected samples are mostly remnant tissues obtained from patients undergoing therapeutic surgical procedures at the Center. The core also ensures tissue release compliance with USF-IRB and Privacy Board recommendations. * Protocol driven sample collection, processing and distribution * Collection of sample and patient demographic information. * Nucleic acid extractions from tissue sections, FNA, core biopsies blood and bone marrow. * Histology services: H&E slides, staining, sectioning, paraffin blocks, OCT blocks, sample microdissection * WBC, plasma and serum isolation. * Project development and support: Facility staff provides advice and guidance to researchers. | cancer, liquid cancer, solid primary tumor, solid tumor, metastatic tumor, malignant, benign, normal, tumor, clinical data, h&e slide, stain, section, paraffin block, oct block, sample microdissection, white blood cell, plasma, serum, private (moffitt cancer center), research |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Moffitt Cancer Center |
Cancer, Normal, Malignant, Benign, Tumor | Private, (Moffitt Cancer Center) | nlx_143721 | http://www.moffitt.org/Site.aspx?spid=2DB275A62C464E15B6E7039BCEA1EB43 | SCR_004406 | 2026-02-11 10:56:53 | 0 | ||||||
|
Tumorbank Bern Resource Report Resource Website |
Tumorbank Bern (RRID:SCR_004611) | TBB | biomaterial supply resource, tissue bank, material resource | Tumorbank Bern - TBB collects high quality clinical samples since 2003 for translational research selected by expert pathologists under controlled conditions of normal and diseased tissue from different origin. The Tumor Bank is approved by the Ethical Commission of Bern, we only collect samples with written informed patient consent. Origin of Tissue: Thoracic Surgery, Gynecology, Urology, Visceral Surgery, Orthopedic Surgery, Head and Neck Surgery, Neurosurgery Tumorbank Bern TBB holds 12,000 samples from 3600 Patients. Please contact us to check if we have samples for your field of research. | tissue, tumor, cancer, normal, diseased, clinical, thoracic, gynecology, urology, visceral, orthopedic, head and neck, neurosurgery |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Bern; Bern; Switzerland |
Tumor, Cancer, Normal, Diseased | Bernese Cancer League | Public: Please contact us to check if we have samples for your field of research. | nlx_60955 | SCR_004611 | Tumorbank Bern TBB, Tumorbank Bern - TBB, Tumor Bank Bern | 2026-02-11 10:56:56 | 0 | |||||
|
Ontario Tumour Bank Resource Report Resource Website 1+ mentions |
Ontario Tumour Bank (RRID:SCR_004732) | OTB | biomaterial supply resource, tissue bank, material resource | The Ontario Tumour Bank is a province-wide biorepository and data bank focused on collection of tumor-related human biospecimens. It provides academic and industry cancer researchers with a diverse selection of high quality tumor-related specimens and data obtained directly by dedicated tumour bank staff, who follow a stringent set of procedures and ethical guidelines. The biospecimens and clinical data are an important resource for scientists engaged in translational research who are developing better diagnostic tools and new drug therapies. Researchers depend on the Ontario Tumour Bank to provide research biospecimens of high quality, diversity, and integrity. Operating at state-of-the-art hospitals and cancer centers across Ontario, the Ontario Tumour Bank coordinates the collection, storage, analysis, annotation, and distribution of tumor and peripheral blood samples. Working in collaboration with local pathologists, medical oncologists, surgeons and other hospital personnel, specially trained staff obtain patient consent, collect tissues and assemble comprehensive clinical information about each donor and the corresponding samples. |
is listed by: One Mind Biospecimen Bank Listing is related to: Canadian Tumour Repository Network has parent organization: Ontario Institute for Cancer Research |
Tumor | Government of Ontario | nlx_74199 | SCR_004732 | Ontario Tumor Bank | 2026-02-11 10:57:02 | 1 | |||||||
|
Andalusian Regional Tumour Bank Resource Report Resource Website |
Andalusian Regional Tumour Bank (RRID:SCR_004885) | biomaterial supply resource, tissue bank, material resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 16, 2013. Located in Spain, the Andalusian Regional Tumour Bank is a regional tumor bank. In the last decades cancer knowledge is growing exponentially due human genome knowledge and technological advantages. However, this disease is the biggest problem of health in Europe, with more than 2,5 million new cases per year. The diagnosis and treatment of cancer is now allowing to identify the characteristics that the disease has on each person. The next step is meant to be a great revolution in the treatment of cancer. This scientific development is dependent on the availability of human tumour samples preserved in demanding conditions. Current technology requires the availability of tissue morphological and molecular conditions similar to those that had the sample before being removed. Tumor banks are responsible for these new quality requirements to foster the development of research and health care of patients. | tumor tissue, tissue, tumor, cancer | is listed by: One Mind Biospecimen Bank Listing | Tumor, Cancer | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_85675 | SCR_004885 | Andalusian Regional Tumor Bank, Red de Bancos de Tumores de Andalucia | 2026-02-11 10:56:59 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
